⚡ Interrogation des APIs scientifiques en cours…
⚡ Interrogation des APIs scientifiques en cours…
Authors' conclusion
Does not affect the score
Publi-Score
Fidelity
Abstract (PubMed)
BACKGROUND: Dietary cholesterol has been suggested to increase the risk of cardiovascular disease (CVD), which has led to US recommendations to reduce cholesterol intake. OBJECTIVE: The authors examine the effects of dietary cholesterol on CVD risk in healthy adults by using systematic review and meta-analysis. DESIGN: MEDLINE, Cochrane Central, and Commonwealth Agricultural Bureau Abstracts databases were searched through December 2013 for prospective studies that quantified dietary cholesterol. Investigators independently screened citations and verified extracted data on study and participant characteristics, outcomes, and quality. Random-effect models meta-analysis was used when at least 3 studies reported the same CVD outcome. RESULTS: Forty studies (17 cohorts in 19 publications with 361,923 subjects and 19 trials in 21 publications with 632 subjects) published between 1979 and 2013 were eligible for review. Dietary cholesterol was not statistically significantly associated with any coronary artery disease (4 cohorts; no summary RR), ischemic stroke (4 cohorts; summary RR: 1.13; 95% CI: 0.99, 1.28), or hemorrhagic stroke (3 cohorts; summary RR: 1.09; 95% CI: 0.79, 1.50). Dietary cholesterol statistically significantly increased both serum total cholesterol (17 trials; net change: 11.2 mg/dL; 95% CI: 6.4, 15.9) and low-density lipoprotein (LDL) cholesterol (14 trials; net change: 6.7 mg/dL; 95% CI: 1.7, 11.7 mg/dL). CONCLUSION: Reviewed studies were heterogeneous and lacked the methodologic rigor to draw any conclusions regarding the effects of dietary cholesterol on CVD risk.
Coeff. authors = avg(1.00, 0.85) = 0.93
Coeff. editorial = avg(0.90, 0.90) = 0.90
min(0.93, 0.90) = 0.90← lowest dominates
Final coefficient : 0.90
Final score = 41.5/52.8 × 0.90 × 100 = 71/100
Saturated fat, carbohydrate, and cardiovascular disease.
Siri-Tarino PW — 2010 · The American journal of clinical nutrition
Contrasted resultsIntensive lipid lowering with atorvastatin in patients with stable coronary disease
LaRosa JC — 2005 · The New England Journal of Medicine
Contrasted resultsEvolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
Sabatine MS — 2017 · The New England journal of medicine
Contrasted resultsEzetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP — 2015 · The New England journal of medicine
Contrasted resultsRosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
Ridker PM — 2008 · New England Journal of Medicine